2506 — Xunfei Healthcare Technology Co Income Statement
0.000.00%
- HK$12.83bn
- HK$12.43bn
- CNY733.98m
Annual income statement for Xunfei Healthcare Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 372 | 472 | 556 | 734 |
Cost of Revenue | ||||
Gross Profit | 188 | 231 | 315 | 404 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 481 | 715 | 742 | 900 |
Operating Profit | -108 | -244 | -186 | -166 |
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | -111 | -244 | -187 | -172 |
Provision for Income Taxes | ||||
Net Income After Taxes | -89.4 | -209 | -154 | -138 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -83.7 | -189 | -145 | -133 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -83.7 | -189 | -145 | -133 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.658 | -1.56 | -1.18 | -0.891 |